iBreastExam - Innovative Detection Device for Early Breast Cancer

How I Serve

I search for emerging companies, technologies, disruptive technologies, 

innovations, start-ups and up-starts. I’ll look to match potential problems… 

e.g. “plastic pollution” to solutions… e.g. 3D Printer for recycled plastic waste…

for potential venture capitalists, angel investors, and online funders. 

I’ll also highlight a variety of topics including funding success stories, 

the environment, housing, medical, artificial intelligence, science, 

aging populations, disabled populations, social entrepreneurs, philanthropy, 

and topical news. I’m always searching for great people innovating, 

inventing, and doing, great things.

The 411: Saving Lives when you're not Close to Medical Care
Found on: http://www.ibreastexam.com/

"Breast cancer is on a rise and India is showing alarming rates of the rise in breast cancer. Early detection of breast cancer can be of some help as it can be cured before becoming fatal to the person. This revolutionary device can even be handled by community health workers.

Started in 2015 by Mihir Shah, Matthew Campisi and Bhaumik Sanghvi in Mumbai, iBreast can detect even the early signs of breast cancer at medical checkup camps thus saving lives of millions of women across India."

Impact innovation one milestone at a time

Quick & Painless Breast Exams For ALL

iBreastExam is an easy breast exam usable by health workers everywhere

iBE™ sensor technology was invented at Drexel University in Philadelphia

Translational research and commercialization of iBreastExam innovation is backed by R&D funding from:

• Drexel University (Coulter Program)
• University City Science Center (QED & DHA)
• Pennsylvania Dept of Health (CURE Grant) 
• Unitus Seed Fund (StartHealth)

iBE™'s sensors accurately assess & identify tissue elasticity differences between hard & stiff breast tumors versus normal breast tissue. The patented tactile sensor technology using Piezoelectric Sensor Array, invented by the scientists and doctors at Drexel University is a novel, quantitative and low-cost elastic modulus (E) and shear modulus (G) sensor that can measure tissue compression and shear stiffness either by top down or lateral touching of the skin surface. iBE™’s ability to apply a force and measure the displacement electrically, all within the sensor, makes for an ideal ‘electronic palpation’ sensor for in-vivo breast imaging.

Clinical Studies Published in the Indian Journal of Gynecologic Oncology, World Journal of Surgical Oncology & the Journal of American College of Surgeons

A major clinical study evaluating iBE™ technology was recently published in the Indian Journal of Gynecologic Oncology in June 2016. The study showed that iBreastExam device can significantly enhance clinical breast examination sensitivity (by 19%) while maintaining high specificity and Negative Predictive Value (NPV). The study concluded that iBreastExam can be a promising tool for early detection of clinically relevant lesions at early stages and also useful in younger women with dense breasts. Here's a link to the peer-reviewed publication.​

Another clinical study titled "A cost-effective handheld breast scanner for use in low-resource environments: a validation study" published in the World Journal of Surgical Oncology on Oct 28, 2016. iBE correctly identified 66 lesions demonstrating sensitivity of 86% and specificity of 89%. Here's a link to the peer-reviewed publication.

The first clinical study evaluating iBE™ technology was published in the Journal of the American College of Surgeons (Volume 216, Issue 6 , Pages 1168-1173, June 2013). This study demonstrated that iBE™ technology could confidently detect invasive lesions/tumors that the physician could not feel with his hands (meaning non-palpable lesions). iBE™ also performed very well in the younger age group (below 40) in detecting small masses. Here's a link to the peer-reviewed publication.